MAY 11, 2016 5:00 AM PDT

Drug calms immune system after brain injuries

Scientists are testing a new drug that could minimize the risk of life-threatening infections in patients with traumatic brain injuries.
"If our findings can be translated into humans this could be life-changing for patients with head injuries," says Claire Harris.

The infections, as well as brain inflammation, are the result of the body’s natural disease-fighting immune response, called “complement.”

“When tissue is injured in an accident, this part of our immune system sees the tissue as ‘foreign’ and responds in an inappropriate way to make the damage even worse,” says Claire Harris, a professor from Cardiff University’s Institute of Infection and Immunity, who led the research.

Harris and colleagues have engineered a new duel “homing” agent that, when given to mice, inactivated the complement system in the brain, reduced inflammation, and aided recovery.

“Widespread blocking of this part of the immune system after traumatic brain injury helps damaged brain tissue to survive and improves neurological recovery in mice. Unfortunately, this treatment approach could be harmful to humans because complement is essential for fighting infections—that’s why this homing agent is so significant.

“We have engineered a drug that combines two different activities in one molecule. One arm ‘targets’ the drug to the site of tissue damage, thus concentrating the therapy exactly where it is most needed, and the second arm (CD59) inhibits a specific part of the complement system that would drive further damage if left unchecked.

“This drug therefore delivers therapy to where it is needed, freeing up the complement system to fight infection in the rest of the body.”

The study, published in the Proceedings of the National Academy of Sciences, showed that when the homing agent was injected into mice immediately after traumatic brain injury, it specifically targeted the injured tissue, serving to inactivate the complement system and reduce inflammation and neuronal damage.

“Development of this new homing agent is exciting. We’ve shown that it can be administered in mice some time after the trauma and still be effective,” says Harris. “If our findings can be translated into humans this could be life-changing for patients with head injuries.”

Source: Cardiff University

This article was originally published on
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
APR 13, 2020
Cannabis Sciences
APR 13, 2020
Smoking Cannabis Increases COVID-19 Risk
Health experts from the National Institute on Drug Abuse and the American Lung Association have said that smoking cannab ...
APR 17, 2020
Drug Discovery & Development
APR 17, 2020
Gilead's Remdesivir Trial Sees Rapid Recoveries from COVID-19
Early results from a Chicago hospital treating patients with Gilead Sciences’ antiviral drug remdesivir for severe ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
MAY 19, 2020
MAY 19, 2020
The Mystery of the Life-Saving Vaccine Solved
In the early 1900s, French bacteriologists Albert Calmette and Camille Guerin spent the better half of a decade developi ...
JUN 04, 2020
Clinical & Molecular DX
JUN 04, 2020
Low T Cells Linked To High COVID Risk
  German scientists have found a link between immune cell counts and the risk of developing severe, potentially lif ...
JUN 19, 2020
Cell & Molecular Biology
JUN 19, 2020
Learning More About How Cells Control a Death Pathway
Scientists have published complementary studies in Nature Communications that have greatly advanced our understanding of ...
Loading Comments...